where to source retatrutide How works: mechanism of action and onset explained Retatrutide - “Triple G” |

Are we capturing downstream savings or just seeing upfront drug cost

One in eight Americans are taking or have taken a glucagon-like peptide-1 receptor agonist (GLP-1)

They do not treat the autoimmune process No clinical evidence demonstrates that GLP-1 receptor agonists reduce thyroid antibody levels or modify the autoimmune destruction of thyroid tissue

Cardiac events included arrhythmias, hypertension, myocardial infarction, ischemic stroke and heart failure

Nieto LM, Martinez J, Narvaez SI, et al

Allowing for small, incremental dose adjustments may improve tolerability and optimize long-term treatment outcomes